Introduction
Activation of peripheral T-effector cells by presented antigens can result in diverging effects for the affected cell. Depending on the "strength" of interaction between the antigen/major histocompatibility complex (MHC) and the T-cell receptor (TCR) complex and the involvement of coreceptors, a resting T cell can be stimulated to produce lymphokines and to proliferate, to become anergic, or to die by apoptosis. Activation Induced Cell Death (AICD) is a particular form of apoptosis that is of pivotal importance for the termination of the immune response and, therefore, homeostasis of the immune system. One important pathway of AICD in lymphocytes is the activation of caspase cascade through so-called death receptors, that is, a subgroup of the tumor necrosis factor (TNF)/ nerve growth factor (NGF)-receptor family that comprise Fas, TNF-receptor I, TNF-related apoptosis-inducing ligand (TRAIL), and further receptors. 1 Their stimulation leads to the activation of caspase cascade and, in turn, to cleavage of death substrates and, finally, to apoptosis of T cells.
However, the activation of caspase cascade through death receptors is not the only mechanism by which AICD of lymphocytes is executed. Thus, superantigen (SAg) injection into triplemutant mice deficient in Fas and TNF-receptor I ϩ II expression led to rapid AICD of V␤8 ϩ T cells, as rapid as those from control animals. This demonstrates that neither Fas nor TNF-mediated signaling pathways are involved in SAg-mediated AICD. 2 Instead, SAg-activated T cells showed a distinct rise in reactive oxygen species (ROS), which are known to mediate apoptosis by damaging mitochondrial enzymes, disintegrating mitochondrial membranes, and releasing cytochrome c from mitochondria. The activation of caspase cascade by cytochrome c is regulated by a large number of antiapoptotic and proapoptotic molecules, which belong to the family of Bcl-2-like proteins. 3 For the apoptosis of lymphocytes, the activity of Bcl-2 and Bim appears to be of particular importance. Bim belongs to the class of "BH-3 only" proteins and binds to Bcl-2, thereby blocking its antiapoptotic activity. 4 Either overexpression of Bcl-2, such as in human follicular lymphomas bearing the t(14;18) translocation or in transgenic mice, 3 or inactivation of Bim in mice 5 resulted in a drastic increase in the number of lymphocytes due to severe defects in apoptosis.
In spite of numerous studies on apoptosis of lymphocytes, relatively little is known about lymphoid-specific signaling molecules and pathways involved in AICD induced by TCR triggering or other mechanisms. The observation that TCR/CD3 stimulation of Jurkat T cells, which induces AICD, also induces activity of HPK1, whereas CD28 stimulation, which provides a survival signal for T cells, did not show any effect on HPK1 activity 6, 7 prompted us to investigate whether HPK1 regulates apoptosis of T cells. We show here that overexpression of HPK1 accelerates both spontaneous and ␣CD3-mediated apoptosis and up-regulates FasL expression on peripheral CD4 ϩ T cells. Moreover, overexpression of HPK1 in EL-4 cells promoted ROS-mediated apoptosis, whereas expression of HPK1 AS-RNA, which impairs HPK1 expression, reduced ROS-mediated apoptosis. When overexpressed in primary T cells, both the N-and C-terminal portions of HPK1, which accumulate after caspase cleavage, were found to promote AICD.
Since the released C-terminal HPK1 peptide suppresses nuclear factor (NF)-B activity 8 one may conclude that HPK1 supports apoptosis by 2 mechanisms, that is, by inducing c-Jun N-terminal kinase (JNK) activation and NF-B inhibition.
Materials and methods

Cells, DNA transfections, reporter gene assays, and retroviral infections
Murine EL-4 thymoma cells were grown in RPMI medium containing 5% fetal calf serum (FCS) and human 293T embryonic kidney (HEK) cells in Dulbecco modified Eagle medium (DMEM) containing 10% FCS. Human 293 cells were transfected with DNA using SuperFect according to Qiagen's protocol. For the determination of NF-B activity, a luciferase reporter gene driven by 3 B sites from the c-myb intronic enhancer 9 was cotransfected with HPK1 expression vectors into EL-4 cells using a conventional diethylaminoethyl (DEAE)-dextran transfection protocol. After 42 hours, the cells were either left untreated or induced with 500 M H 2 O 2 for 6 hours. Luciferase assays were performed 48 hours after transfection, as described previously. 10 EL-4 cells stably transduced with recombinant retroviruses were selected with zeocin (250 nM) for 7 days. HPK1 expression was tested in Western blots, and enhanced green fluorescent protein (EGFP) fluorescence was checked by a fluorescence-activated cell-sorter scanner (FACS). DO11.10 TCR transgenic (tg) BALB/c mice 11 were killed between 6 and 8 weeks of age. CD4 ϩ T cells from lymph nodes (LNs) were isolated by passing them through CD4 T-cell recovery columns (Cedarlane, Hornby, Canada) according to the manufacturer's protocol. The cells were cultured at 5 ϫ 10 5 /mL in X-VIVO15 (Bio Whittaker) supplemented with 5% FCS, Gln, nonessential amino acids, pyruvate (all 2 mM), antibiotics (penicillin, streptomycin), and 5 ϫ 10 -5 M 2-mercaptoethanol. Dendritic cells were prepared from irradiated spleen and used as antigen-presenting cells (APCs). CD4 ϩ T cells were stimulated by the cognate ovalbumin peptide (OVA)-peptide (323-339) presented on APCs and cultured in the presence of interleukin (IL)-2 as described. 12 After 24 hours, they were infected with retroviruses as described previously. 13 Induction and determination of apoptosis TCR-mediated apoptosis of primary T cells infected with retroviruses was induced 4 or 5 days after primary stimulation by incubating cells on petri dishes coated with 5 g/mL mAb (145-2C11, PharMingen) specific for CD3⑀. After 8 hours, cells were stained with Annexin V-PE (PharMingen) according to the manufacturer's protocol. The effect of HPK1 on apoptosis was determined by FACS dividing the Annexin V-PE positive and infected cells by all infected cells (ϫ 100). Apoptosis of EL-4 cells was induced, after careful washing, by incubation of 5 ϫ 10 5 cells per milliliter fresh medium containing 1 mM H 2 O 2. Apoptosis was determined by FACS either using Annexin V-PE staining or a slightly modified SubG 1 technique. 14 
Retroviral constructs
The bicistronic retroviral vector pEGZ-HA is based on the vector pczCFG2 hCD8 EYZ in which the cytomegalovirus (CMV) enhancer replaces the U3 region of the 5Ј long terminal repeat (LTR) of murine leukemia virus (for further details, see Berberich-Siebelt et al 13 ). An oligonucleotide was cloned into its EcoRI site, creating a start codon and HA-Flag epitope followed by ClaI, AscI, BsiWI, RsrlI, HpaI, and SacII sites, which facilitate "in frame" cloning of cDNAs. The retroviral vector expressing wild-type (wt) HPK1, pHA-HPK1 wt contains the cDNA (amino acids 2-833) of human HPK1, 15 which was amplified by polymerase chain reaction (PCR) and cloned between the ClaI/HpaI sites of pEGZ-HA. A mutated version of HPK1, pHA-HPK1 M(46) containing a K46 to M46 substitution 15 was used to test a kinase-inactive version of HPK1. The pHA-HPK1 wt N-terminus (encoding amino acid [aa] 2-385) and C-terminus constructs (aa 386-833) were created by cloning PCR products into pEGZ-HA. In addition, a kinase-inactive (K46 to M46) version of pHA-HPK1 wt N-terminus was also constructed. The retroviral AS vector, pHA-HPK1 AS, bears the sequences 386-2 between its ClaI/HpaI sites. All DNA modifying enzymes were purchased from MBI Fermentas (St Leon-Rot, Germany).
Antibodies and Western blot assays
Antibodies (Abs) raised against HPK1 (N-19; sc-6231), phospho-Tyr (PY99; sc-7020), IB␣ (C-21; sc-371), Erk1 (K23; sc-94), JNK1 (C-17; sc-474), p-JNK (G-7; sc-6254), and p38 (C-20; sc-535) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Abs detecting phosphoErk1/2 (Thr202/Tyr204) or phospho-p38 (Thr180/Tyr182) were purchased from Cell Signaling Technology (Beverly, MA), a mAb against ␤-actin (AC-15) was obtained from Sigma-Aldrich (Taufkirchen, Germany). A biotin-conjugated mAb against murine FasL was obtained from Alexis Corporation (Grünberg, Germany), and PE-conjugated streptavidin from PharMingen (Heidelberg, Germany). The mAb HA.11 raised against HA tag was purchased from BAbCO (Richmond, VA).
In Western blots, an indicated amount of whole cellular protein lysate was fractionated by 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted onto nitrocellulose membrane. For detection of proteins, appropriate peroxidase-coupled secondary Abs were used with a standard enhanced chemiluminescence system (Amersham, Freiburg, Germany).
Protein kinase assays
For in vitro phosphorylation with immunoprecipitated protein kinases, 500 g of whole cell protein extract from 293 HEK cells transfected with retroviral vectors was incubated with the HA.11 mAb. Immune complexes were collected onto protein G-sepharose beads and, after washing with immunoprecipitation (IP) buffer, used to phosphorylate 10 g GST/ c-Jun 5-89 in 30 L kinase buffer containing 20 M adenosine 5-triphosphate (ATP) and 5 Ci (1.8 ϫ 10 5 Bq) of 32 P-␥-ATP. 16 After 20 minutes at 37°C, proteins were fractionated by 12.5% SDS-PAGE followed by autoradiography.
Results
HPK1 enhances ␣CD3-mediated apoptosis of primary T lymphocytes
Stimulation of primary T lymphocytes from DO 10.11 tg mice (which have initially been activated with the cognate OVA peptide) by Abs raised against CD3 (␣CD3Abs), a proapoptotic stimulus, for 3 hours leads to a more than 3-fold increase in HPK1 protein levels ( Figure 1A ). This finding and the observation that ␣CD3ϩCD28Abs but not ␣CD28Ab stimulation alone enhanced HPK1 activity 7 prompted us to investigate whether HPK1 plays a physiological role in T-cell apoptosis. To this end, we transduced primary murine CD4 ϩ T cells with retroviruses expressing wt HPK1 (pHA-HPK1 wt) or a kinase-inactive version of HPK1 bearing a K46 to M46 substitution (pHA-HPK1 M[46]). 15 As shown in Figure 1B , the viral vectors encoding HPK1 protein bear a fusion gene consisting of an N-terminally tagged HA epitope and HPK1 cDNA, which is linked via an internal ribosomal entry site (IRES) to EGFP and zeocin gene (Zeo). Therefore, HPK1, the EGFP fluorescence marker and zeocin resistance genes are coordinately expressed. In control experiments, transfection of 293T cells with constructs encoding the wt but not the kinase-inactive HPK1 mutant led in in vitro kinase assays to the autophosphorylation of HPK1 and phosphorylation of GST-cJun , which was added as an exogenous substrate ( Figure 1C) . CD4 ϩ T cells from DO 11.10 TCR tg mice were infected with HPK1-expressing retroviruses 1 day after primary stimulation, and
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HPK1 enhances apoptosis induction of EL-4 thymoma cells by ROS
In order to elucidate molecular mechanisms of HPK1-mediated apoptosis, we established lines of retrovirally infected EL-4 thymoma cells overexpressing different versions of HPK1 protein. These were treated with H 2 O 2 , which enhances the levels of free ROS that are important mediators of apoptosis in T cells. 2 Treatment of EL-4 cells with 1 mM H 2 O 2 for 5 to 120 minutes increased the level of endogenous HPK1 (Figure 2A ), whereas those of other protein kinases, such as of Erk, JNK and p38 mitogen-activated protein (MAP) kinases, remained constant (Figure 3) . In addition, H 2 O 2 treatment led to an increase in level of N-terminal HPK1 peptide containing the HPK1 kinase domain ( Figure 1B ). This released N-terminal peptide was shown to exhibit an enhanced kinase activity compared to full-size HPK1. 17 When EL-4 cells overexpressing HPK1 were treated with 1 mM H 2 O 2 , a 40% increase in apoptosis was detected after 8 hours compared to cells infected with the pEGZ-HA control vector ( Figure 2B ). While cells overexpressing the kinase-inactive HPK1 M(46) showed a moderate increase in apoptosis (of approximately 15%, data not shown), cells expressing HPK1 AS-RNA were markedly more resistant against H 2 O 2 -mediated apoptosis than control cells ( Figure 2B ). Since expression of HPK1 AS-RNA suppressed HPK1 levels ( Figure 2C) activity, that of wt HPK1 resulted in a pronounced longer-lasting JNK1 activation. This indicates that at least a part of JNK activation was due to HPK1 kinase activity and not to its adaptor function. Compared to JNK1 activation, a more moderate increase in p38 and Erk activation was observed in cells expressing HPK1. However, almost the same inducible effect was detected in cells expressing HPK1 M(46), suggesting that HPK1 activity plays a minor role for p38 and Erk induction. The increased activity of all 3 MAP kinases but not their expression could be suppressed by HPK1 AS-RNA (Figure 3 , panel pHA-HPK1 AS), indicating that overexpression of HPK1 stimulates all 3 MAP kinase signaling cascades, although to a very different extent.
A marked increase in JNK activation by HPK1 was also observed in primary CD4 ϩ T cells infected with a retrovirus expressing HPK1. This is shown in Figure 4 , where a distinct, stronger JNK1 phosphorylation can be seen in untreated cells and cells stimulated with ␣CD3Abs for 30 minutes. In contrast, a subtle or no increase in phosphorylation was detected for p38 and Erk1/2 kinases (Figure 4 ).
Both N-and C-terminal HPK1 peptides promote apoptosis of CD4 ؉ T cells
The rapid cleavage of HPK1 after H 2 O 2 treatment in EL-4 cells (Figure 2A , middle panel) prompted us to investigate whether the cleavage products of HPK1 (presumably generated by caspase 3 8, 17 ) support apoptosis of primary T cells. To this end, we constructed viruses expressing either the N-terminal cleavage product comprising aa 2-385 or the C-terminal product comprising aa 386-833 ( Figure 5B ) and infected CD4 ϩ T cells after primary stimulation. As summarized in Figure 5A , similar to cells infected with HA-HPK1 wt virus, infection with viruses expressing one of the two cleavage products resulted in an increase of spontaneous apoptosis from approximately 20% to 30-33% and of ␣CD3-mediated apoptosis from 50.5% to 70-75% 3 days after primary stimulation. Interestingly, expressing a kinase-inactive version of N-terminal cleavage product (pH-HPK1 M(46) N-terminus) was without effect on apoptosis. In addition, infection with virusexpressing HPK1 AS-RNA impaired slightly spontaneous and ␣CD3-mediated apoptosis ( Figure 5A ). These data demonstrate that in HPK1-promoted apoptosis, both the N-and C-terminal portions of HPK1 are involved.
HPK1 modulates NF-B activation
In order to show whether HPK1 influences NF-B activation under the conditions of apoptosis induction in EL-4 and primary T cells, we cotransfected first EL-4 cells with a luciferase reporter gene driven by multiples of NF-B binding sites from the c-myb promoter, with vectors expressing HPK1 wild-type or HPK1 C-terminal peptide. Treatment of HPK1 wt-transfected cells with 500 M H 2 O 2 led to a 3-to 4-fold increase in NF-B-driven luciferase activity compared to cells transfected with a control "empty" vector. In contrast, a 2-to 3-fold decrease in NF-B activity was observed for cells transfected with a HPK1 C-terminusexpressing construct ( Figure 6A ). This shows that HPK1 wt protein 
A suppressive effect of HPK1 C-terminus peptide on NF-B activation was also detected in primary CD4 ϩ T cells. In Western blots studying the degradation of cytosolic NF-B-inhibitor IB␣ after ␣CD3 stimulation for 30 minutes, we observed that IB␣ is partially degraded in primary T cells infected with a control "empty" virus EGZ-HA or HPK1 wt-expressing virus but not with a virus expressing the C-terminal portion of HPK1 ( Figure 6B ).
HPK1 enhances FasL expression of primary T lymphocytes
FasL is a key molecule in AICD of peripheral T cells. Therefore, we also investigated if HPK1 can modulate the expression level of FasL. After 3 days of infection with pEGZ-HA control virus, approximately 20% of primary T cells expressed FasL, whereas approximately 40% of cells infected with HPK1 virus were found to express FasL (Figure 7) . Induction of both cell types through CD3 led to an increase in number of FasL-expressing cells to approximately 40% and 60%, respectively. HPK1 AS-RNA, on the other hand, only slightly affected FasL expression. These findings show that HPK1 can enhance FasL expression, but mechanisms in addition to the FasL/Fas signaling cascade are involved in HPK1-mediated apoptosis of primary T cells.
Discussion
HPK1 is a member of the family of germinal center kinases that is predominantly expressed in adult hematopoietic tissues. It has originally been described as an upstream Ser/Thr protein kinase of the JNK signaling cascade. 15, 18 Recently, it was shown that TCR stimulation leads to a rapid but transient activation of HPK1 and its binding to the linker of activated T cells (LAT) and the adaptor proteins Nck, Crk, and Gads. HPK1, which also binds to the signaling molecules SLP-76, Grb2, Grap, and CrkL is localized in lipid rafts and needs lck and ZAP70 for its activation. 6, 7, 20 These data suggested an involvement of HPK1 in the signaling transfer from the TCR to downstream signaling cascades. However, the role for HPK1 in T-cell physiology remained to be shown.
We show here that one of the functions of HPK1 activation upon T-cell stimulation is to control the termination of immune response by supporting apoptosis of T cells. This is demonstrated by overexpressing wt HPK1, which led to a substantial increase in spontaneous and ␣CD3-mediated apoptosis, as well as to FasL expression on CD4 ϩ T cells (Figures 1, 5, and 7) . In contrast, expression of HPK1 AS-RNA exerted a slight, albeit measurable, suppressive effect on both apoptosis and FasL expression. Apoptosis suppression by overexpressing HPK1 AS-RNA was much more pronounced in H 2 O 2 -treated EL-4 cells in which HPK1 overexpression stimulated cell death induced by ROS (Figure 2 ), indicating that HPK1 indeed controls apoptosis in T cells.
Two prominent downstream signaling cascades, the JNK and NF-B pathways, both of which modulate apoptosis, were shown to be stimulated by HPK1. 8, 15, 18, 19 (Figures 3, 4, and 6 ). Whereas NF-B factors, in particular RelA/p65, exert a strong antiapoptotic activity, 21 the 2 JNK kinases, JNK1 and 2, are potent inducers of apoptosis of thymocytes and peripheral T cells. [22] [23] [24] It is likely that the substantial increase in AICD that we observed for primary T cells after infection with virus-expressing HPK1 (Figure 1 ) is due to the modulation of these 2 signaling pathways. However, inhibition of JNK activity in primary T cells by the JNK inhibitor SP600125 (Calbiochem, Bad Soden, Germany) did not lead to a complete suppression of HPK1-enhanced apoptosis induction (data not shown), and in addition to JNK activation, H 2 O 2 treatment of HPK1-infected EL-4 cells led also to a moderate increase of ERK activity, in particular in pHA-HPK1 M(46)-infected cells (see Ling et al 6 and Figure 3 ). This indicates that signaling events others than JNK and NF-B activation are involved in HPK1-mediated apoptosis induction. One of them might be the scaffolding function of HPK1 through its Proline-rich motifs by binding the SLP-76-related adaptor Clnk 25 or other signaling molecules.
H 2 O 2 treatment exerted a strong and, in particular, sustained JNK1 activation in EL-4 cells infected with HPK1-expressing virus (Figure 3) . In primary murine embryo fibroblasts deficient for JNK1 and 2, the defect in inducible apoptosis was localized to the mitochondria. 26 Therefore, one may assume that effector molecules involved in mitochondrial apoptosis resistance, such as Bcl-2, are the targets of enhanced JNK activity in EL-4 cells. Both Bcl-2 and Bcl-X L , a further member of antiapoptotic group of Bcl-2-like proteins, were described to be phosphorylated and inactivated by JNKs in vivo. 27, 28 In spite of disagreement with other studies, the Bcl-2-like proteins, including the BH3-only protein Bim and its relatives, appear to be potential targets of JNK in regulating mitochondrial apoptosis induction (see Davis 29 for a discussion). 
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Taken together, these results lead to a model in which, during the initial phase of T-cell activation, the rapid and transient HPK1 induction provides both proapoptotic and antiapoptotic signals by activating JNK and NF-B signaling pathways, respectively. At a later stage, due to the accumulation of the C-terminal HPK1 cleavage product, NF-B activation is suppressed, and the balance between survival and apoptotic signals is shifted, favoring apoptosis. However, signaling events in addition to the stimulation of JNK and inhibition of NF-B signaling cascades might also be involved in the HPK1-mediated control of T-cell apoptosis. The nature of these events remains to be elucidated.
